Skip to main content
. 2018 Jan 31;8(1):15–21. doi: 10.5826/dpc.0801a04

Figure 2.

Figure 2

Adverse effects reported with intravenous glutathione injections by the Food and Drug Administration, Department of Health, Republic of the Philippines [5] and the intravenous GSH trial by Zubair et al. [15] [Copyright: ©2018 Sonthalia et al.]